Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
Preprint
Abstract
Antiviral therapeutics to treat SARS-CoV-2 are much desired for the on-going pandemic. A well-precedented viral enzyme is the main protease (MPro), which is now targeted by an approved drug and by several investigational drugs. With the inevitable liabilities of these new drugs, and facing viral resistance, there remains a call for new chemical scaffolds against MPro. We virtually docked 1.2 billion non-covalent and a new library of 6.5 million electrophilic molecules against the enzyme structure. From these, 29 non-covalent and 11 covalent inhibitors were identified in 37 series, the most potent having an IC 50 of 29 μM and 20 μM, respectively. Several series were optimized, resulting in inhibitors active in the low micromolar range. Subsequent crystallography confirmed the docking predicted binding modes and may template further optimization. Together, these compounds reveal new chemotypes to aid in further discovery of MPro inhibitors for SARS-CoV-2 and other future coronaviruses.Keywords
All Related Versions
- Published version: Protein Science, 32 (8), e4712.
This publication has 84 references indexed in Scilit:
- Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4Proceedings of the National Academy of Sciences, 2012
- Towards automated crystallographic structure refinement with phenix.refineActa Crystallographica Section D Structural Biology, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-LactamaseJournal of Medicinal Chemistry, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Scaling and assessment of data qualityActa Crystallographica Section D Structural Biology, 2005